USD 13.29
(8.92%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 2.14 Billion USD | 3.37% |
2022 | 2.07 Billion USD | 1.68% |
2021 | 2.03 Billion USD | 7.6% |
2020 | 1.89 Billion USD | 3.67% |
2019 | 1.82 Billion USD | -0.27% |
2018 | 1.83 Billion USD | 3.83% |
2017 | 1.76 Billion USD | 4.52% |
2016 | 1.68 Billion USD | 2.3% |
2015 | 1.65 Billion USD | -4.83% |
2014 | 1.73 Billion USD | 1.97% |
2013 | 1.7 Billion USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 556.7 Million USD | -48.37% |
2024 Q2 | 556.7 Million USD | 0.0% |
2023 Q4 | 1.07 Billion USD | 98.41% |
2023 Q3 | 543.45 Million USD | -48.51% |
2023 Q2 | 1.05 Billion USD | 100.0% |
2023 FY | 2.14 Billion USD | 3.37% |
2023 Q1 | 527.75 Million USD | -51.06% |
2022 Q3 | 514 Million USD | -50.79% |
2022 Q2 | 1.04 Billion USD | 100.0% |
2022 FY | 2.07 Billion USD | 1.68% |
2022 Q1 | 522.25 Million USD | -49.78% |
2022 Q4 | 1.07 Billion USD | 109.79% |
2021 Q3 | 515.15 Million USD | -48.89% |
2021 FY | 2.03 Billion USD | 7.6% |
2021 Q4 | 1.03 Billion USD | 101.86% |
2021 Q2 | 1 Billion USD | 100.0% |
2021 Q1 | 504 Million USD | -47.97% |
2020 Q2 | 908 Million USD | 100.0% |
2020 Q3 | 493.15 Million USD | -45.69% |
2020 Q4 | 968.63 Million USD | 96.42% |
2020 Q1 | 454 Million USD | -52.26% |
2020 FY | 1.89 Billion USD | 3.67% |
2019 Q2 | 888.9 Million USD | 100.0% |
2019 Q1 | 444.45 Million USD | -2.4% |
2019 Q3 | 469.15 Million USD | -47.22% |
2019 FY | 1.82 Billion USD | -0.27% |
2019 Q4 | 950.91 Million USD | 102.69% |
2018 FY | 1.83 Billion USD | 3.83% |
2018 Q4 | 455.4 Million USD | 0.0% |
2018 Q3 | 455.4 Million USD | -1.14% |
2018 Q2 | 460.65 Million USD | 0.0% |
2018 Q1 | 460.65 Million USD | -1.29% |
2017 Q1 | 415.65 Million USD | -3.27% |
2017 Q2 | 415.65 Million USD | 0.0% |
2017 Q3 | 466.65 Million USD | 12.27% |
2017 Q4 | 466.65 Million USD | 0.0% |
2017 FY | 1.76 Billion USD | 4.52% |
2016 Q1 | 403.7 Million USD | -7.26% |
2016 Q4 | 429.7 Million USD | 0.0% |
2016 Q2 | 425.2 Million USD | 5.33% |
2016 Q3 | 429.7 Million USD | 1.06% |
2016 FY | 1.68 Billion USD | 2.3% |
2015 Q2 | 408.1 Million USD | 3.47% |
2015 Q4 | 435.3 Million USD | 5.5% |
2015 FY | 1.65 Billion USD | -4.83% |
2015 Q1 | 394.4 Million USD | -2.95% |
2015 Q3 | 412.6 Million USD | 1.1% |
2014 Q1 | 429.3 Million USD | -6.82% |
2014 Q3 | 453.2 Million USD | 1.84% |
2014 Q4 | 406.4 Million USD | -10.33% |
2014 FY | 1.73 Billion USD | 1.97% |
2014 Q2 | 445 Million USD | 3.66% |
2013 Q2 | 427.8 Million USD | 13.66% |
2013 FY | 1.7 Billion USD | 0.0% |
2013 Q1 | 376.4 Million USD | 0.0% |
2013 Q3 | 435.8 Million USD | 1.87% |
2013 Q4 | 460.7 Million USD | 5.71% |
Name | Revenue | Revenue Difference |
---|---|---|
American Medical Technologies Inc. | 3.19 Million USD | -67028.856% |
Ansell Limited | 1.61 Billion USD | -32.304% |
Ansell Limited | 1.61 Billion USD | -32.304% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 184.64 Million USD | -1060.265% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 135.05 Thousand USD | -1586216.686% |
Psykey, Inc. | 419.29 Thousand USD | -510848.035% |
ConvaTec Group Plc | 2.19 Billion USD | 2.353% |
Encision Inc. | 6.58 Million USD | -32430.191% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | 1.82 Million USD | -117296.605% |
LifePoint, Inc. | -18.5 Thousand USD | 11580640.541% |
Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -31345.765% |
Paradigm Medical Industries, Inc. | 772 Thousand USD | -277412.953% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 986.22 Thousand USD | -217133.477% |
Reflect Scientific, Inc. | 1.08 Million USD | -198242.088% |
SmileDirectClub, Inc. | 470.74 Million USD | -355.11% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | -14.468% |
SheerVision, Inc. | 3.49 Million USD | -61121.801% |
United Health Products, Inc. | - USD | -Infinity% |
Vasamed, Inc. | 1.38 Million USD | -154441.533% |
Wearable Health Solutions, Inc. | 745.09 Thousand USD | -287434.576% |
Yubo International Biotech Limited | 104.28 Thousand USD | -2054309.635% |